Kane Biotech Inc (KNE) — Cash Flow Quality Index
Kane Biotech Inc (KNE) has a Cash Flow Quality Index of -0.24x as of June 2024. Operating cash flow of CA$-2.17 Million is below net income of CA$9.18 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Kane Biotech Inc assets under control for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kane Biotech Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Kane Biotech Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Kane Biotech Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Kane Biotech Inc (2024–2024)
Year-by-year earnings quality comparison for Kane Biotech Inc. For live market cap and the full company financial profile, see market value of Kane Biotech Inc.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.67x | CA$-4.11 Million | CA$6.10 Million | — |